- Home
- OST vs MBRX Comparison
OST vs MBRX Comparison
Compare OST & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- MBRX
- Stock Information
- Founded
- OST 2010
- MBRX 2015
- Country
- OST China
- MBRX United States
- Employees
- OST N/A
- MBRX N/A
- Industry
- OST Industrial Machinery/Components
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- MBRX Health Care
- Exchange
- OST Nasdaq
- MBRX Nasdaq
- Market Cap
- OST 15.7M
- MBRX 17.1M
- IPO Year
- OST 2022
- MBRX 2016
- Fundamental
- Price
- OST $1.66
- MBRX $0.38
- Analyst Decision
- OST
- MBRX Strong Buy
- Analyst Count
- OST 0
- MBRX 4
- Target Price
- OST N/A
- MBRX $5.00
- AVG Volume (30 Days)
- OST 185.8K
- MBRX 4.0M
- Earning Date
- OST 09-19-2025
- MBRX 11-07-2025
- Dividend Yield
- OST N/A
- MBRX N/A
- EPS Growth
- OST N/A
- MBRX N/A
- EPS
- OST N/A
- MBRX N/A
- Revenue
- OST $38,333,251.00
- MBRX N/A
- Revenue This Year
- OST N/A
- MBRX N/A
- Revenue Next Year
- OST N/A
- MBRX N/A
- P/E Ratio
- OST N/A
- MBRX N/A
- Revenue Growth
- OST 0.34
- MBRX N/A
- 52 Week Low
- OST $1.35
- MBRX $0.25
- 52 Week High
- OST $235.00
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- OST 26.79
- MBRX 32.94
- Support Level
- OST $1.50
- MBRX $0.35
- Resistance Level
- OST $2.07
- MBRX $0.62
- Average True Range (ATR)
- OST 0.23
- MBRX 0.05
- MACD
- OST 1.49
- MBRX -0.02
- Stochastic Oscillator
- OST 19.14
- MBRX 8.19
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.